The emerging NIR-II imaging modality is promising for real-time visualization of living systems and multiple disease diagnoses,particularly through its enhanced tissue penetration and superior spatial resolution[1,2]....The emerging NIR-II imaging modality is promising for real-time visualization of living systems and multiple disease diagnoses,particularly through its enhanced tissue penetration and superior spatial resolution[1,2].Cyanine dyes possess the advantages of low administration dosage,high biocompatibility,and strong fluorescence emission intensity[3].Cyanine dyes can be easily structurally modified through molecular engineering methods,while the large hydrophobic conjugation systems hinder further in vivo imaging application.The traditional surfactant encapsulation strategy cannot effectively solve the aggregation caused-quenching issue of the dyes in aqueous solutions and may even mask their reaction active sites[4].Due to the special hydrophobic pocket to act as a probe carrier and the ability to serve as the pan-marker for multiple diseases,albumin is chosen as the preferred binding protein for cyanine dyes[5].Albumin interacts with cyanine dyes through a“hydrophobic pocket”and further improves its properties such as water solubility,biosafety,and fluorescence quantum yield.Cyanine dyes can modify the binding efficiency with albumin through structural design and regulate the targeting performance.This means that cyanine-tagged albumin can respond to pathological changes caused by different diseases and monitor the disease process in real time with high contrast through NIR-II fluorescence signals.Further development of cyanine-tagged albumin probes is helpful for in-depth comprehension of the binding mechanism and guiding the directed synthesis of cyanine molecules with specific protein binding behaviors and optical properties,thereby achieving precise targeting and high-performance NIR-II bioimaging of specific diseases.This point is essential for the design,preparation,and even clinical translation of NIR-II targeting dye molecules in precise diagnosis and treatment.展开更多
基金supported by the Project for Enhancing the Scientific Research and Innovation Capacity of Doctoral Students of the Education Department of Jilin Province(JJKH20250061BS).
文摘The emerging NIR-II imaging modality is promising for real-time visualization of living systems and multiple disease diagnoses,particularly through its enhanced tissue penetration and superior spatial resolution[1,2].Cyanine dyes possess the advantages of low administration dosage,high biocompatibility,and strong fluorescence emission intensity[3].Cyanine dyes can be easily structurally modified through molecular engineering methods,while the large hydrophobic conjugation systems hinder further in vivo imaging application.The traditional surfactant encapsulation strategy cannot effectively solve the aggregation caused-quenching issue of the dyes in aqueous solutions and may even mask their reaction active sites[4].Due to the special hydrophobic pocket to act as a probe carrier and the ability to serve as the pan-marker for multiple diseases,albumin is chosen as the preferred binding protein for cyanine dyes[5].Albumin interacts with cyanine dyes through a“hydrophobic pocket”and further improves its properties such as water solubility,biosafety,and fluorescence quantum yield.Cyanine dyes can modify the binding efficiency with albumin through structural design and regulate the targeting performance.This means that cyanine-tagged albumin can respond to pathological changes caused by different diseases and monitor the disease process in real time with high contrast through NIR-II fluorescence signals.Further development of cyanine-tagged albumin probes is helpful for in-depth comprehension of the binding mechanism and guiding the directed synthesis of cyanine molecules with specific protein binding behaviors and optical properties,thereby achieving precise targeting and high-performance NIR-II bioimaging of specific diseases.This point is essential for the design,preparation,and even clinical translation of NIR-II targeting dye molecules in precise diagnosis and treatment.
